Indication
Myxedema
Myxedema refers to an advanced clinical state of severe hypothyroidism, as well as the characteristic dermatologic change resulting from profound thyroid hormone deficiency. Read more about Myxedema
3 drugs 3 manufacturers
Drugs that treat it
Common Myxedema therapies.
TRIOSTAT (liothyronine sodium)
TRIOSTAT (liothyronine sodium)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonMyxedema refers to an advanced clinical state of severe hypothyroidism, as well as the characteristic dermatologic change resulting from profound thyroid hormone deficiency.
It primarily impacts the endocrine and integumentary systems, frequently affecting adult populations—especially older individuals and women with long-standing or inadequately managed thyroid disease.
Pathophysiologically, sustained thyroid hormone insufficiency promotes widespread interstitial accumulation of hydrophilic glycosaminoglycans, leading to mucinous nonpitting edema, facial puffiness, coarse dry skin, and broad metabolic slowing.
Without intervention, this systemic hypometabolic state can deteriorate into myxedema coma, a critical medical emergency marked by hypothermia, profound lethargy or altered sensorium, bradycardia, and multiorgan decompensation.
- nih.gov
Myxedema refers to an advanced clinical state of severe hypothyroidism, as well as the characteristic dermatologic change resulting from profound thyroid hormone deficiency Pathophysiologically, sustained thyroid hormone insufficiency promotes widespread interstitial accumulation of hydrophilic glycosaminoglycans, leading to mucinous nonpitting edema, facial puffiness, coarse dry skin, and broad metabolic slowing Without intervention, this systemic hypometabolic state can deteriorate into myxede...
- pfizer.com
Myxedema refers to an advanced clinical state of severe hypothyroidism, as well as the characteristic dermatologic change resulting from profound thyroid hormone deficiency It primarily impacts the endocrine and integumentary systems, frequently affecting adult populations—especially older individuals and women with long-standing or inadequately managed thyroid disease Pathophysiologically, sustained thyroid hormone insufficiency promotes widespread interstitial accumulation of hydrophilic glyco...
- nih.gov
It primarily impacts the endocrine and integumentary systems, frequently affecting adult populations—especially older individuals and women with long-standing or inadequately managed thyroid disease
- healthline.com
It primarily impacts the endocrine and integumentary systems, frequently affecting adult populations—especially older individuals and women with long-standing or inadequately managed thyroid disease
- mhsystem.org
Pathophysiologically, sustained thyroid hormone insufficiency promotes widespread interstitial accumulation of hydrophilic glycosaminoglycans, leading to mucinous nonpitting edema, facial puffiness, coarse dry skin, and broad metabolic slowing
- mdsearchlight.com
Pathophysiologically, sustained thyroid hormone insufficiency promotes widespread interstitial accumulation of hydrophilic glycosaminoglycans, leading to mucinous nonpitting edema, facial puffiness, coarse dry skin, and broad metabolic slowing
- nih.gov
Without intervention, this systemic hypometabolic state can deteriorate into myxedema coma, a critical medical emergency marked by hypothermia, profound lethargy or altered sensorium, bradycardia, and multiorgan decompensation
Personalize your experience
Follow Myxedema and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.